Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 803789, 6 pages
http://dx.doi.org/10.1155/2014/803789
Research Article

The Influence of pH and Temperature on the Stability of N-[(Piperidine)methylene]daunorubicin Hydrochloride and a Comparison of the Stability of Daunorubicin and Its Four New Amidine Derivatives in Aqueous Solutions

1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, 6 Grunwaldzka Street, 60-780 Poznań, Poland
2Department of Oncological Surgery II, Greater Poland Cancer Centre, 15 Garbary Street, 61-688 Poznań, Poland
3Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, 5 Starościńska Street, 02-515 Warsaw, Poland

Received 29 August 2013; Accepted 24 December 2013; Published 6 February 2014

Academic Editors: A. Nokhodchi, M. Ozyazici, and C. Pichon

Copyright © 2014 Mikołaj Piekarski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Piekarski and A. Jelińska, “Anthracyclines still prove effective in anticancer therapy,” Mini-Reviews in Medicinal Chemistry, vol. 13, no. 5, pp. 627–634, 2013. View at Publisher · View at Google Scholar
  2. G. N. Hortobágyi, “Anthracyclines in the treatment of cancer. An overview,” Drugs, vol. 54, no. 4, pp. 1–7, 1997. View at Google Scholar
  3. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, “Anthracyclines: molecular advances and pharmacologie developments in antitumor activity and cardiotoxicity,” Pharmacological Reviews, vol. 56, no. 2, pp. 185–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. B. Weiss, “The anthracyclines: will we ever find a better doxorubicin?” Seminars in Oncology, vol. 19, no. 6, pp. 670–686, 1992. View at Google Scholar · View at Scopus
  5. M. Wasowska, J. Wietrzyk, A. Opolski, J. Oszczapowicz, and I. Oszczapowicz, “Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells,” Anticancer Research, vol. 26, no. 3, pp. 2009–2012, 2006. View at Google Scholar · View at Scopus
  6. J. Madej, S. Dzimira, and M. Wąsowska, “New derivatives of anthracycline antibiotics with lower cardiotoxicity,” Journal Chemotherapy, vol. 16, pp. 154–158, 2004. View at Google Scholar
  7. M. Ripamonti, L. Capolongo, G. Melegaro et al., “Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives,” Investigational New Drugs, vol. 14, no. 2, pp. 139–146, 1996. View at Google Scholar · View at Scopus
  8. E. Fan, W. Shi, and T. L. Lowary, “Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues,” Journal of Organic Chemistry, vol. 72, no. 8, pp. 2917–2928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-G. Gao, W. Priebe, and A. H. Wang, “Substitutions at C2′ of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity,” European Journal of Biochemistry, vol. 240, no. 2, pp. 331–335, 1996. View at Google Scholar · View at Scopus
  10. J. Pawłowska, J. Tarasiuk, E. Borowski, M. W̧sowska, I. Oszczapowicz, and C. R. Wolf, “The ability of new formamidine sugar-modified derivatives of daunorubicin to stimulate free radical formation in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase and xanthine oxidase,” Acta Biochimica Polonica, vol. 47, no. 1, pp. 141–147, 2000. View at Google Scholar · View at Scopus
  11. M. Wąsowska, J. Oszczapowicz, I. Oszczapowicz, and A. Owoc, Patent C07H 15/252, 2006.
  12. F. Arcamone, F. Animati, G. Capranico et al., “New developments in antitumor anthracyclines,” Pharmacology and Therapeutics, vol. 76, no. 1–3, pp. 117–124, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wasowska, I. Oszczapowicz, J. Wietrzyk et al., “Influence of the structure of new anthracycline antibiotics on their biological properties,” Anticancer Research, vol. 25, no. 3, pp. 2043–2048, 2005. View at Google Scholar · View at Scopus
  14. E. Ciesielska, K. Studzian, M. W̧sowska, I. Oszczapowicz, and L. Szmigiero, “Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety,” Cell Biology and Toxicology, vol. 21, no. 3-4, pp. 139–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Beijnen, O. A. G. J. Van der Houwen, M. C. H. Voskuilen, and W. J. M. Underberg, “Aspects of the degradation kinetics of daunorubicin in aqueous solution,” International Journal of Pharmaceutics, vol. 31, no. 1-2, pp. 75–82, 1986. View at Google Scholar · View at Scopus
  16. J. Cielecka-Piontek, A. Jelińska, M. Zajac, M. Sobczak, A. Bartold, and I. Oszczapowicz, “A comparison of the stability of doxorubicin and daunorubicin in solid state,” Journal of Pharmaceutical and Biomedical Analysis, vol. 50, no. 4, pp. 576–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Wood, W. J. Irwin, and D. K. Scott, “Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography,” Journal of Clinical Pharmacy and Therapeutics, vol. 15, no. 4, pp. 291–300, 1990. View at Google Scholar · View at Scopus
  18. M. J. Wood, W. J. Irwin, and D. K. Scott, “Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags,” Journal of Clinical Pharmacy and Therapeutics, vol. 15, no. 4, pp. 279–289, 1990. View at Google Scholar · View at Scopus
  19. R. Chevrier, V. Sautou, V. Pinon, F. Demeocq, and J. Chopineau, “Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion,” Pharmaceutica Acta Helvetiae, vol. 70, no. 2, pp. 141–148, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Beijnen, H. Rosing, A. De Vries Ph., and W. J. M. Underberg, “Stability of anthracycline antitumour agents in infusion fluids,” Journal of Parenteral Science and Technology, vol. 39, no. 6, pp. 220–222, 1985. View at Google Scholar · View at Scopus
  21. G. K. Poochikian, J. C. Cradock, and K. P. Flora, “Stability of anthracycline antitumor agents in four infusion fluids,” American Journal of Hospital Pharmacy, vol. 38, no. 4, pp. 483–486, 1981. View at Google Scholar · View at Scopus
  22. J. Karlsen, H. Thonnensen, O. Resberg, S. Horne, and T. J. Skobba, “Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment,” Norvegica Pharmaceutica Acta, vol. 45, no. 2, pp. 61–67, 1983. View at Google Scholar · View at Scopus
  23. J. Cielecka-Piontek, A. Jelińska, A. Dołhań et al., “Stability of new anticancer agents in intravenous solutions,” Asian Journal of Chemistry, vol. 24, no. 2, pp. 769–772, 2012. View at Google Scholar
  24. M. Lłukawska, I. Oszczapowicz, A. Jelińska et al., “Development and validation of RP-HPLC method for determination of novel derivatives of daunorubicin,” Chemia Analityczna, vol. 54, no. 5, pp. 907–917, 2009. View at Google Scholar · View at Scopus
  25. E. Pawełczyk and T. Hermann, The Fundamentals of Stability of Drugs, PZWL, Warsaw, Poland, 1982 (Polish).
  26. A. Krause, A. Jelińska, J. Cielecka-Piontek et al., “Acid-base catalysis of N-[(morpholine)methylene]-daunorubicin,” Drug Development and Industrial Pharmacy, vol. 38, no. 8, pp. 1024–1028, 2012. View at Publisher · View at Google Scholar
  27. P. Zalewski, M. Zajac, A. Jelinska, J. Cielecka-Piontek, and I. Oszczapowicz, “Stability study of anticancer agent N-[(Hexahydroazepin-1-yl)methyl] daunorubicin in Aqueous Solutions Using HPLC method,” Asian Journal of Chemistry, vol. 23, no. 2, pp. 835–838, 2011. View at Google Scholar · View at Scopus
  28. A. Jelińska, J. Uszak, J. Cielecka-Piontek et al., “Stability of [(N-pyrrolidine)metylene]daunorubicin in aqueous solutions,” Reaction Kinetics and Catalysis Letters, vol. 98, no. 1, pp. 69–75, 2009. View at Publisher · View at Google Scholar · View at Scopus